SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-06-000146
Filing Date
2006-01-19
Accepted
2006-01-18 18:40:08
Documents
10
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER form6k.htm 6-K 6848
2 PRESS RELEASE - NOVEMBER 14, 2005 exhibit99-1.htm EX-99.1 49674
3 MATERIAL CHANGE REPORT - CARDIOME REPORTS THIRD QUARTER RESULTS exhibit99-2.htm EX-99.2 60144
4 INTERIM FINANCIAL STATEMENTS FOR THE QUARTER ENDED SEPTEMBER 30, 2005 exhibit99-3.htm EX-99.3 259901
5 CERTIFICATION OF FILINGS - CFO exhibit99-4.htm EX-99.4 3374
6 CERTIFICATION OF FILINGS - CEO exhibit99-5.htm EX-99.5 3397
7 PRESS RELEASE - DECEMBER 9, 2005 exhibit99-6.htm EX-99.6 7269
8 MATERIAL CHANGE REPORT - CARDIOME INITIATES PHASE 2A STUDY FOR ORAL RSD1235 exhibit99-7.htm EX-99.7 11867
9 cardiome.gif GRAPHIC 5700
10 line.gif GRAPHIC 808
  Complete submission text file 0001062993-06-000146.txt   413170
Mailing Address 6190 AGRONOMY RD. 6TH FLOOR VANCOUVER A1 V6T 1Z3
Business Address 6190 AGRONOMY RD. 6TH FLOOR VANCOUVER A1 V6T 1Z3 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1130
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 06536529
SIC: 2834 Pharmaceutical Preparations